@article {5954,
	title = {Estrogen plus progestin treatment: Effect of different progestin components on serum markers of apoptosis in healthy postmenopausal women},
	journal = {Fertility and Sterility},
	volume = {94},
	year = {2010},
	month = {2010///},
	pages = {2399 - 2401},
	abstract = {One hundred healthy postmenopausal women were randomly assigned to receive 17β-E2 1 mg/drospirenone 2 mg or 17β-E2 1 mg/norethisterone acetate 0.5 mg for 6 months, and circulating soluble Fas, soluble Fas ligand, and cytochrome c were measured at baseline and at 6 months in 87 women who completed the study. Although cytochrome c levels were undetectable, circulating soluble Fas/soluble Fas ligand ratio decreased in both groups, suggesting a decrease in ligand-mediated apoptosis. Copyright {\textcopyright} 2010 American Society for Reproductive Medicine, Published by Elsevier Inc.},
	keywords = {apoptosis, cyt-c, drospirenone, Estrogen, Fas, FasL, hormone therapy, norethisterone, progestin},
	author = {Karaflou, M. and Kaparos, G. and Rizos, D. and Creatsa, M. and Christodoulakos, G. and Lambrinoudaki, I.}
}
